Glenn Grossman

Glenn Grossman is an accomplished professional with a strong background in commercial analytics in the healthcare industry. With a focus on leading teams and implementing advanced methodological approaches, he excels in optimizing analytical strategies for both commercial and government healthcare clients. His expertise lies in healthcare business evaluation, forecasting, and optimization, particularly in the pharmaceutical sector. He has an extensive track record in developing and managing advanced patient analytics, deriving key insights to drive strategy across various stages of the pharmaceutical lifecycle.

Glenn Grossman's key skill areas include multifunctional portfolio management, advanced epidemiologic methods, demand forecasting, predictive modeling, persuasive communication, artificial intelligence analytics, and performance measurement. With a strong educational foundation from Rutgers Prep, the University of North Carolina at Chapel Hill, and Tufts University, Glenn brings a wealth of knowledge and expertise to his roles.

Throughout his career, Glenn Grossman has held key positions in reputable organizations such as Novartis, The Medicines Company, Sanofi, Bristol-Myers Squibb, and Booz Allen Hamilton. His experience spans from being the Head of Commercial Analytics to Global Director of Forecasting, Insights and Analytics, showcasing his versatility and depth of knowledge in the field.